C&EN article by Shi En Kim
November 13, 2022 | A version of this story appeared in Volume 100, Issue 40
IN BRIEF:
The lack of gravity in space opens up unique opportunities for drug design and development. With the influx of commercial entities providing access to low-Earth orbit, both the discovery and manufacture of drugs in space may one day become practical, affordable—and, perhaps, commonplace.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.
The XXVI. EFMC International Symposium on Medicinal Chemistry will be held as a virtual event between August 29 – September 2, 2021. InnoStudio will contribute to the programme from the space chemistry point of view, by presenting its poster ”Novel method to improve...
InnoStudio was honored to be invited to the roundtable discussion at ESA’s In-Orbit Economy workshop on July 20, 2021. President & CEO Dr. Ferenc Darvas talked about how to bridge the gap between zero gravity innovation and commercial solutions by chemistry. You...
We are pleased to inform you that InnoStudio will hold a presentation, entitled „Effect of microgravity on COVID-19 drug formulation on ISS” at ISSRDC 2021, the 10th Annual International Space Station Research and Development Conference on August 16 in the Biology and...
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
